These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25196534)

  • 1. Using Web searches to track interest in synthetic cannabinoids (a/k/a 'herbal incense').
    Curtis B; Alanis-Hirsch K; Kaynak Ö; Cacciola J; Meyers K; McLellan AT
    Drug Alcohol Rev; 2015 Jan; 34(1):105-8. PubMed ID: 25196534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products.
    Santacroce R; Corazza O; Martinotti G; Bersani FS; Valeriani G; Di Giannantonio M
    Hum Psychopharmacol; 2015 Jul; 30(4):265-71. PubMed ID: 26216561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
    J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?
    Meyers K; Kaynak Ö; Bresani E; Curtis B; McNamara A; Brownfield K; Kirby KC
    Int J Drug Policy; 2015 Jul; 26(7):670-4. PubMed ID: 25641258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'.
    Kneisel S; Westphal F; Bisel P; Brecht V; Broecker S; Auwärter V
    J Mass Spectrom; 2012 Feb; 47(2):195-200. PubMed ID: 22359329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon.
    Jerry J; Collins G; Streem D
    Cleve Clin J Med; 2012 Apr; 79(4):258-64. PubMed ID: 22473725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spicing things up: synthetic cannabinoids.
    Spaderna M; Addy PH; D'Souza DC
    Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spice drugs: cannabinoids as a new designer drugs].
    Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
    Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.
    Brents LK; Prather PL
    Drug Metab Rev; 2014 Feb; 46(1):72-85. PubMed ID: 24063277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey study to characterize use of Spice products (synthetic cannabinoids).
    Vandrey R; Dunn KE; Fry JA; Girling ER
    Drug Alcohol Depend; 2012 Jan; 120(1-3):238-41. PubMed ID: 21835562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.
    Cottencin O; Rolland B; Karila L
    Curr Pharm Des; 2014; 20(25):4106-11. PubMed ID: 24001292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
    Seely KA; Lapoint J; Moran JH; Fattore L
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):234-43. PubMed ID: 22561602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.
    Järbe TU; Gifford RS
    Life Sci; 2014 Feb; 97(1):64-71. PubMed ID: 23891559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Internet Snapshot Survey Assessing the sale of Synthetic Cannabinoid Receptor Agonists for use with Electronic Vaping Devices.
    Gould A; Dargan PI; Wood DM
    J Med Toxicol; 2024 Sep; 20(3):271-277. PubMed ID: 38839732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From "herbal highs" to the "heroin of cannabis": Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum.
    Bilgrei OR
    Int J Drug Policy; 2016 Mar; 29():1-8. PubMed ID: 26860324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.
    Law R; Schier J; Martin C; Chang A; Wolkin A;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):618-9. PubMed ID: 26068566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
    Auwärter V; Dresen S; Weinmann W; Müller M; Pütz M; Ferreirós N
    J Mass Spectrom; 2009 May; 44(5):832-7. PubMed ID: 19189348
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.